Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neoplasms, Squamous Cell × zalutumumab × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms, Squamous Cell 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

Cisplatin 3 Cetuximab 3 pembrolizumab 2 zalutumumab 1 temsirolimus 1 osimertinib 1 cobimetinib 1 Taxes 1 Sorafenib 1 Radiotherapy 1 Pemetrexed 1 Paclitaxel 1 Nivolumab 1 Injections 1 Fluorouracil 1 Cilengitide 1 Carboplatin 1 Biological Products 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00401401 2011-12-23

Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer

Genmab

Phase 1/2 Terminated

30 enrolled 13 charts

Head and Neck Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡